1
|
Ozeki S, Tatematsu N, Sugiura H. Physical and emotional status, quality of life and activities of daily living in terminal cancer: prospective cohort study. BMJ Support Palliat Care 2024:spcare-2024-005032. [PMID: 39317428 DOI: 10.1136/spcare-2024-005032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2024] [Accepted: 09/10/2024] [Indexed: 09/26/2024]
Abstract
OBJECTIVE Physical functioning (PF), emotional functioning (EF), overall quality of life (QOL) and activities of daily living (ADL) such as walking and toilet transfer are the primary outcomes of dignity in patients with terminal cancer. However, few studies have investigated the association of PF, EF and overall QOL with ADL based on end-of-life stages in patients with cancer who are receiving at-home palliative care. METHODS This prospective cohort study included 88 patients with terminal cancer receiving home-based rehabilitation as part of their home-based palliative care at the Mariana Home Nursing Station (Nagoya-city, Aichi, Japan). The variables were measured at 4 and 2 weeks before death of patients. PF, EF and overall QOL scores were assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care and ADL were assessed using the Functional Independence Measure-motor items. Multiple regression analysis was used to examine the association, considering the effect of physical symptoms. RESULTS PF and overall QOL scores at 4 and 2 weeks before death were significantly associated with toilet transfer and walking scores, even after considering the influence of physical symptoms. EF scores were significantly associated with toilet transfer and walking scores 4 weeks before death, but not 2 weeks before death. CONCLUSIONS In addition to managing physical symptoms, supporting ADL such as walking and toilet transfer is necessary to maintain PF, EF and overall QOL in patients with terminal cancer receiving home-based palliative care. This may help preserve their dignity, even in deteriorating general condition.
Collapse
Affiliation(s)
- Shinya Ozeki
- Mariana Home-Nursing Station, Nagoya, Aichi, Japan
- Department of Integrated Health Sciences, Nagoya University, Nagoya, Japan
| | - Noriatsu Tatematsu
- Department of Integrated Health Sciences, Nagoya University, Nagoya, Japan
| | - Hideshi Sugiura
- Department of Integrated Health Sciences, Nagoya University, Nagoya, Japan
| |
Collapse
|
2
|
Stene GB, Balstad TR, Leer ASM, Bye A, Kaasa S, Fallon M, Laird B, Maddocks M, Solheim TS. Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia. Cancers (Basel) 2019; 11:cancers11121925. [PMID: 31816924 PMCID: PMC6966581 DOI: 10.3390/cancers11121925] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2019] [Revised: 11/20/2019] [Accepted: 11/22/2019] [Indexed: 12/20/2022] Open
Abstract
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexia trials, but there is a lack of data on how these outcomes interact over time. The aim of this secondary analysis of data from a trial investigating multimodal intervention for cancer cachexia (ClinicalTrials.gov: NCT01419145) is to explore whether changes in muscle mass and PF are associated with weight loss and cachexia status at baseline. Methods: Secondary analysis was conducted using data from a phase II randomized controlled trial including 46 patients with stage III–IV non-small cell lung cancer (n = 26) or inoperable pancreatic cancer (n = 20) due to commence chemotherapy. Cachexia status at baseline was classified according to international consensus. Muscle mass (assessed using computed tomography (CT)) and PF outcomes, i.e., Karnofsky performance status (KPS), self-reported PF (self-PF), handgrip strength (HGS), 6-minute walk test (6MWT), and physical activity (PA), were measured at baseline and after six weeks. Results: When compared according to cachexia status at baseline, patients with no/pre-cachexia had a mean loss of muscle mass (−5.3 cm2, p = 0.020) but no statistically significant change in PF outcomes. Patients with cachexia also lost muscle mass but to a lesser extent (−2.8 cm2, p = 0.146), but demonstrated a statistically significant decline in PF; KPS (−3.8 points, p = 0.030), self-PF (−8.8 points, p = 0.027), and HGS (−2.7 kg, p = 0.026). Conclusions: Weight loss history and cachexia status at baseline are of importance if one aims to detect changes in PF outcomes in cancer cachexia trials. To improve the use of co-primary endpoints that include PF in future trials, outcomes that have the potential to detect change relative to weight loss should be investigated further.
Collapse
Affiliation(s)
- Guro Birgitte Stene
- Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway;
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway; (T.R.B.); (S.K.); (B.L.); (T.S.S.)
- Cancer Clinic, Trondheim University Hospital, 7491 Trondheim, Norway
- Correspondence: ; Tel.: +47-48226799
| | - Trude Rakel Balstad
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway; (T.R.B.); (S.K.); (B.L.); (T.S.S.)
- Cancer Clinic, Trondheim University Hospital, 7491 Trondheim, Norway
| | - Anne Silja M. Leer
- Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway;
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway; (T.R.B.); (S.K.); (B.L.); (T.S.S.)
| | - Asta Bye
- Department of Nursing and Health Promotion, Faculty of Health Sciences, OsloMet—Oslo Metropolitan University, 0167 Oslo, Norway;
- Regional Advisory Unit for Palliative Care, Department of Oncology, Oslo University Hospital, 0167 Oslo, Norway
| | - Stein Kaasa
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway; (T.R.B.); (S.K.); (B.L.); (T.S.S.)
- Cancer Clinic, Trondheim University Hospital, 7491 Trondheim, Norway
- European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, 0167 Oslo, Norway
| | - Marie Fallon
- Edinburgh Cancer Research Centre, University of Edinburgh, Crewe Road, Edinburgh EH4 2XR, UK;
| | - Barry Laird
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway; (T.R.B.); (S.K.); (B.L.); (T.S.S.)
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK
- St Columba’s Hospice, Boswall Road, Edinburgh EH4 2XR, UK
| | - Matthew Maddocks
- Cicely Saunders Institute of Palliative Care, Policy & Rehabilitation, King’s College London, Bessemer Road, London SE5 9PJ, UK;
| | - Tora S. Solheim
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU—Norwegian University of Science and Technology, 7491 Trondheim, Norway; (T.R.B.); (S.K.); (B.L.); (T.S.S.)
- Cancer Clinic, Trondheim University Hospital, 7491 Trondheim, Norway
| |
Collapse
|
3
|
Krogstad H, Brunelli C, Sand K, Andersen E, Garresori H, Halvorsen T, Haukland EC, Jordal F, Kaasa S, Loge JH, Løhre ET, Raj SX, Hjermstad MJ. Development of EirV3: A Computer-Based Tool for Patient-Reported Outcome Measures in Cancer. JCO Clin Cancer Inform 2019; 1:1-14. [PMID: 30657392 DOI: 10.1200/cci.17.00051] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
PURPOSE Immediate transfer of patient-reported outcome measures (PROMs) for use in medical consultations is facilitated by electronic assessments. We aimed to describe the rationale and development of Eir version 3 (EirV3), a computer-based symptom assessment tool for cancer, with emphasis on content and user-friendliness. METHODS EirV3's specifications and content were developed through multiprofessional, stepwise, and iterative processes (from 2013 to 2016), with literature reviews on traditional and electronic assessment and classification methods, formative iterative usability tests with end-users, and assessment of patient preferences for paper versus electronic assessments. RESULTS EirV3 has the following two modules: Eir-Patient for PROMs registration on tablets and Eir-Doctor for presentation of PROMs in a user-friendly interface on computers. Eir-Patient starts with 19 common cancer symptoms followed by specific, in-depth questions for endorsed symptoms. The pain section includes a body map for pain location and intensity, whereas physical functioning, nutritional intake, and well-being are standard questions for all. Data are wirelessly transferred to Eir-Doctor. Symptoms with intensity scores ≥ 3 (on a 0 to 10 scale) are marked in red, with brighter colors corresponding to higher intensity, and supplemented with graphs displaying symptom development over time. Usability results showed that patients and health care providers found EirV3 to be intuitive, easy to use, and relevant. When comparing PROM assessments on paper versus tablets (n = 114), 19% of patients preferred paper, 41% preferred tablets, and 40% had no preference. Median intraclass correlation coefficient between paper and tablets (0.815) was excellent. CONCLUSION Iterative test rounds followed by continuous improvements led to a user-friendly, applicable symptom assessment tool, EirV3, developed for and by end-users. EirV3 is undergoing international testing of clinical and cross-cultural adaptability.
Collapse
Affiliation(s)
- Hilde Krogstad
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Cinzia Brunelli
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Kari Sand
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Eivind Andersen
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Herish Garresori
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Tarje Halvorsen
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Ellinor C Haukland
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Frode Jordal
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Stein Kaasa
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Jon Håvard Loge
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Erik Torbjørn Løhre
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Sunil X Raj
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| | - Marianne Jensen Hjermstad
- Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
| |
Collapse
|
4
|
|
5
|
Sanvezzo VMDS, Montandon DS, Esteves LSF. Instruments for the functional assessment of elderly persons in palliative care: an integrative review. REVISTA BRASILEIRA DE GERIATRIA E GERONTOLOGIA 2018. [DOI: 10.1590/1981-22562018021.180033] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Abstract Objective: to identify validated instruments that can be used for the functional assessment of elderly persons in Palliative Care. Method: an integrative review focused on identifying instruments for the functional assessment of elderly persons in palliative care was carried out by searching publications in periodicals indexed in seven electronic databases. Descriptors, keywords and Boolean operators were used for a cross-database search in November 2017. A total of 357 abstracts were identified, from which 53 articles were selected for reading, of which 21 met the inclusion criteria. Results: this strategy allowed the identification of eight scales and one test for the functional assessment of elderly persons in palliative care. Conclusion: eight scales and a functional test which also provide guidelines for improving the quality of life of elderly people in palliative care were identified, demonstrating that it is practically impossible to disassociate physical functional performance from social and psychological aspects.
Collapse
|
6
|
Hall E, Tam E, Liang M, Zhang Q, Liu L, Wong L, Sarabia S, Yeung S, Gill G, Eng L, Perez-Cosio A, Brown MC, Xu W, Li M, Mittmann N, Jones J, Howell D, Liu G. Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice. Support Care Cancer 2018; 27:521-530. [PMID: 29982902 DOI: 10.1007/s00520-018-4333-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 06/26/2018] [Indexed: 11/12/2022]
Abstract
PURPOSE A patient's physical function is a critical outcome variable for measuring and improving chronic care management. However, patient-reported outcome measures of physical function are not routinely assessed in cancer outpatients, in part due to limitations of tools available. This study presents the development and evaluation of the Cancer Ambulatory Patient Physical Function Longitudinal Evaluation Tool (CAPLET) as an adaptive response tool for routinely screening for physical dysfunction in oncology clinical practice. METHODS In phase 1, 407 adult outpatients at Princess Margaret Cancer Centre completed the World Health Organization Disability Assessment Schedule (WHODAS) 2.0, Health Assessment Questionnaire Disability Index (HAQ-DI), EuroQuol-5D-3L ( EQ-5D-3L), and patient-reported outcome (PRO)-Eastern Cooperative Oncology Group (ECOG). CAPLET was developed based on a branching logic algorithm navigating patients to appropriate domains of HAQ-DI/WHOAS using their responses to the PRO-ECOG/EQ-5D-3L as screeners. Sensitivity/specificity of CAPLET screeners for HAQ-DI/WHODAS items were reported. In phase 2, CAPLET vs the WHODAS/HAQ-DI were alternatively administrated to 318 adult outpatients in a two-arm trial comparing time to completion and acceptability between the tools. RESULTS Using a patient's ECOG status and the sum of the mobility, self-care, and usual activity dimensions of the EQ-5D-3L to dichotomize patients as with or without difficulty, CAPLET achieved a sensitivity > 90% against recommended WHODAS and HAQ-DI cutoffs for significant dysfunction. Sensitivity of screeners for capturing dysfunction in individual WHODAS/HAQ-DI items ranged from 85 to 100%. Compared to the HAQ-DI/WHODAS, CAPLET was associated with a 50% reduction in administration times and improved patient acceptability, while reducing question burden by 84% for half the sample population. CONCLUSIONS CAPLET improves the feasibility of capturing detailed assessments of patient-reported physical function in cancer outpatients.
Collapse
Affiliation(s)
- Elizabeth Hall
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Emily Tam
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Mindy Liang
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Quihuang Zhang
- Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Lin Liu
- Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Lauren Wong
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Samantha Sarabia
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Sabrina Yeung
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Gursharan Gill
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Lawson Eng
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Andrea Perez-Cosio
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - M Catherine Brown
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Wei Xu
- Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Madeline Li
- Psychosocial Oncology, Princess Margaret Cancer Centre, 610 University Ave., 7-124, Toronto, Ontario, M5G 2M9, Canada
| | | | - Jennifer Jones
- Survivorship Program, Princess Margaret Cancer Centre, Toronto, Canada
| | - Doris Howell
- Psychosocial Oncology, Princess Margaret Cancer Centre, 610 University Ave., 7-124, Toronto, Ontario, M5G 2M9, Canada. .,Lawrence Bloomberg School of Nursing, University of Toronto, Toronto, Canada.
| | - Geoffrey Liu
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. .,Department of Epidemiology, Dalla Lana School of Public Health, Departments of Medicine and Biophysics, University of Toronto, Toronto, Canada.
| |
Collapse
|
7
|
Turriziani A, Attanasio G, Scarcella F, Sangalli L, Scopa A, Genualdo A, Quici S, Nazzicone G, Ricciotti MA, La Commare F. The importance of measuring customer satisfaction in palliative care. Future Oncol 2016; 12:807-13. [PMID: 26837318 DOI: 10.2217/fon.15.359] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
In the last decades, palliative care has been more and more focused on the evaluation of patients' and families' satisfaction with care. However, the evaluation of customer satisfaction in palliative care presents a number of issues such as the presence of both patients and their families, the frail condition of the patients and the complexity of their needs, and the lack of standard quality indicators and appropriate measurement tools. In this manuscript, we critically review existing evidence and literature on the evaluation of satisfaction in the palliative care context. Moreover, we provide - as a practical example - the preliminary results of our experience in this setting with the development of a dedicated tool for the measurement of satisfaction.
Collapse
Affiliation(s)
- Adriana Turriziani
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Gennaro Attanasio
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Francesco Scarcella
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Luisa Sangalli
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Anna Scopa
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Alessandra Genualdo
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Stefano Quici
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | - Giulia Nazzicone
- Hospice Villa Speranza, Università Cattolica del Sacro Cuore, Rome 00168, Italy
| | | | | |
Collapse
|
8
|
Maribo T, Petersen KS, Handberg C, Melchiorsen H, Momsen AMH, Nielsen CV, Leonardi M, Labriola M. Systematic Literature Review on ICF From 2001 to 2013 in the Nordic Countries Focusing on Clinical and Rehabilitation Context. J Clin Med Res 2016; 8:1-9. [PMID: 26668676 PMCID: PMC4676339 DOI: 10.14740/jocmr2400w] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/09/2015] [Indexed: 11/23/2022] Open
Abstract
We present a systematic review on International Classification of Functioning, Disability and Health (ICF) used in the Nordic countries from 2001 through 2013, describing and quantifying the development in utilization of ICF, and describe the extent to which the different components of the ICF have been used. A search was conducted in EMBASE, MEDLINE and PsycInfo. Papers from Nordic countries were included if ICF was mentioned in title or abstract. Papers were assigned to one of eight categories covering the wide rehabilitation area; furthermore, area of focus was assigned. Use of ICF components and intervention were coded in papers categorized as "clinical and/or rehabilitation contexts" or "non-clinical contexts". One hundred seventy papers were included, of these 99 papers were from the categories "clinical and/or rehabilitation contexts" or "non-clinical contexts". Forty-two percent of the 170 included papers were published in the period 2011 - 2013. There was an increase in ICF-relevant papers from 2001 to 2013, especially in the categories "clinical and/or rehabilitation contexts" and "non-clinical contexts". The most represented focus areas were neurology, musculoskeletal, and work-related areas. All five or at least four ICF components were mentioned in the results or discussions in most papers, and activity was most frequently mentioned.
Collapse
Affiliation(s)
- Thomas Maribo
- Section of Social Medicine and Rehabilitation, Department of Public Health, Rehabilitation Center Marselisborg, Aarhus University, Denmark
- Public Health and Quality Improvement, Central Denmark Region, Aarhus, Denmark
| | - Kirsten S. Petersen
- Section of Social Medicine and Rehabilitation, Department of Public Health, Rehabilitation Center Marselisborg, Aarhus University, Denmark
- Public Health and Quality Improvement, Central Denmark Region, Aarhus, Denmark
| | - Charlotte Handberg
- Section of Social Medicine and Rehabilitation, Department of Public Health, Rehabilitation Center Marselisborg, Aarhus University, Denmark
- Public Health and Quality Improvement, Central Denmark Region, Aarhus, Denmark
| | - Hanne Melchiorsen
- Public Health and Quality Improvement, Central Denmark Region, Aarhus, Denmark
| | | | - Claus V. Nielsen
- Section of Social Medicine and Rehabilitation, Department of Public Health, Rehabilitation Center Marselisborg, Aarhus University, Denmark
- Public Health and Quality Improvement, Central Denmark Region, Aarhus, Denmark
| | - Matilde Leonardi
- Neurology Public Health and Disability Unit, Neurological Institute C. Besta, IRCCS Foundation, Milan, Italy
| | - Merete Labriola
- Section of Social Medicine and Rehabilitation, Department of Public Health, Rehabilitation Center Marselisborg, Aarhus University, Denmark
- Public Health and Quality Improvement, Central Denmark Region, Aarhus, Denmark
| |
Collapse
|
9
|
Siemens W, Wehrle A, Gaertner J, Henke M, Deibert P, Becker G. Implementing a home-based exercise program for patients with advanced, incurable diseases after discharge and their caregivers: lessons we have learned. BMC Res Notes 2015; 8:509. [PMID: 26419844 PMCID: PMC4588256 DOI: 10.1186/s13104-015-1523-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2015] [Accepted: 09/21/2015] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Palliative care (PC) patients experience loss of physical function which usually impedes mobility, autonomy and quality of life. We aimed at examining the feasibility of a home-based exercise program for patients with advanced, incurable diseases after discharge. RESULTS This was a single-arm pilot study (WHO-ICTRP: DRKS00005048). The 12-week home-based program comprised strength, balance, flexibility and endurance components. Patients with a presumed life expectancy of 6-12 months were recruited during a 6-months period on a specialized PC and a radiation therapy ward. We chose the De Morton Mobility Index as primary outcome. Secondary outcomes were quality of life, 6-min walk test and others. A total of 145 patients were screened, 103 (98%) out of 105 patients on the specialized PC ward could not be included, mostly because of a low performance status [n = 94; 90%; Eastern Cooperative Oncology Group (ECOG) >2]. The only two eligible patients declined to participate. Eleven out of 40 patients (28%) were eligible on the radiation therapy ward. However, only one patient (9%) participated but dropped out 2 days later (upcoming surgery). Distance to the hospital (n = 3; 30%) and considering additional tasks as "too much" (n = 3; 30%) were most common reasons for non-participation. CONCLUSIONS Establishing a home-based exercise program for inpatients after discharge was not feasible mainly due to non-eligibility and lack of demand. For future trials, we suggest that choosing (1) outpatients with (2) an ECOG of ≤2 and (3) an estimated survival of ≥9 months could enhance participation in home-based exercise programs.
Collapse
Affiliation(s)
- Waldemar Siemens
- Department of Palliative Care, University Medical Center Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.
| | - Anja Wehrle
- Department of Internal Medicine, Institute for Exercise- and Occupational Medicine, University Medical Center Freiburg, Hugstetter Str. 49, 79106, Freiburg, Germany.
| | - Jan Gaertner
- Department of Palliative Care, University Medical Center Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.
| | - Michael Henke
- Department of Radiation Oncology, University Medical Center Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.
| | - Peter Deibert
- Department of Internal Medicine, Institute for Exercise- and Occupational Medicine, University Medical Center Freiburg, Hugstetter Str. 49, 79106, Freiburg, Germany.
| | - Gerhild Becker
- Department of Palliative Care, University Medical Center Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.
| |
Collapse
|
10
|
Mueller K, Hamilton G, Rodden B, DeHeer HD. Functional Assessment and Intervention by Nursing Assistants in Hospice and Palliative Care Inpatient Care Settings. Am J Hosp Palliat Care 2014; 33:136-43. [DOI: 10.1177/1049909114555397] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
This study assessed the impact of a nursing assistant-led functional intervention in an urban hospice. Thirty-three patients participated. A physical therapist trained 4 nursing assistants to assess 4 basic functional activities at admission and discharge and to provide daily activity training to intervention group participants. Control group participants were assessed at admission and discharge and received the usual standard of care. Both groups improved. The intervention group participants demonstrated significant improvement in the Timed up and Go test as well as their self-reported ability to achieve goals on the Patient-Specific Functional Scale. Control group participants made significant improvements in the ability to move from supine to sit in bed. These findings suggest that nursing assistants can provide activity-based assessment and intervention leading to improved function among patients in hospice.
Collapse
Affiliation(s)
- Karen Mueller
- Department of Physical Therapy, Northern Arizona University, Flagstaff, AZ, USA
| | - Gillian Hamilton
- Department of physical therapy and athletic training, Hospice of the Valley, Phoenix, AZ, USA
| | - Betheny Rodden
- Department of physical therapy and athletic training, Hospice of the Valley, Phoenix, AZ, USA
| | - Hendrick D. DeHeer
- Department of Physical Therapy, Northern Arizona University, Flagstaff, AZ, USA
| |
Collapse
|
11
|
de Souza CV, Miranda ECM, Garcia C, Aranha FJP, de Souza CA, Vigorito AC. Functional evaluation indicates physical losses after hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter 2012; 34:345-51. [PMID: 23125542 PMCID: PMC3486824 DOI: 10.5581/1516-8484.20120090] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2012] [Accepted: 06/27/2012] [Indexed: 11/28/2022] Open
Abstract
Objective To perform a function evaluation of patients before and after hematopoietic stem cell transplantation. Methods From November 2008 to November 2010, 29 female (58%) and 21 male patients (42%) with median age of 48 years (range: 24-67) were enrolled in this study. Data collection was performed before and after autologous or allogeneic hematopoietic stem cell transplantation. Evaluation instruments included the 2-minute walking test to evaluate gait performance with assessment of the oxygen saturation, heart rate and Borg Scale before and after the test; grip strength for strength evaluation, Schober Test for spine mobility testing and maximum and adapted activity scores of the Human Activity Profile questionnaire to test functionality in daily activities. Results Fifty patients were evaluated at baseline; six did not undergo hematopoietic stem cell transplantation (three died, one refused and two were excluded). Thus 44/50 (88% - 21 allogeneic and 23 autologous) transplantations were performed. Only 33 of the 44 patients (75%) performed evaluations after transplantation (nine died and two were excluded). Of the patients who performed both evaluations, significantly lower values were found in the evaluation after transplantation for the 2-minute walking test (p-value = 0.004), grip strength of both right and left hands (p-value = 0.004 and p-value < 0.0001, respectively), the Schober Test, and maximum and adapted activity scores (p-value < 0.0001). The heart rate was higher (p-value = 0.01) before the 2-minute walking test and oxygen saturation was higher (p-value = 0.02) after. Conclusion Statistical differences indicate functional impairment after transplantation showing physical losses in this population.
Collapse
|
12
|
Kumar SP. Reporting of "quality of life": a systematic review and quantitative analysis of research publications in palliative care journals. Indian J Palliat Care 2012; 18:59-67. [PMID: 22837613 PMCID: PMC3401736 DOI: 10.4103/0973-1075.97475] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
CONTEXT Palliative care clinical practice depends upon an evidence-based decision-making process which in turn is based upon current research evidence. One of the most important goals in clinical palliative care is to improve patients' quality of life (QoL). AIM This study aimed to perform a quantitative analysis of research publications in palliative care journals for reporting characteristics of articles on QoL. SETTINGS AND DESIGN This was a systematic review of palliative care journals. MATERIALS AND METHODS Twelve palliative care journals were searched for articles with "QoL" in the title of the articles published from 2006 to 2010. The reporting rates of all journals were compared. The selected articles were categorized into assessment and treatment, and subsequently grouped into original and review articles. The original articles were subgrouped into qualitative and quantitative studies, and the review articles were grouped into narrative and systematic reviews. Each subgroup of original article category was further classified according to study designs. STATISTICAL ANALYSIS USED Descriptive analysis using frequencies and percentiles was done using SPSS for Windows, version 11.5. RESULTS The overall reporting rate among all journals was 1.95% (71/3634), and Indian Journal of Palliative Care (IJPC) had the highest reporting rate of 5.08% (3/59), followed by Palliative Medicine (PM) with 3.71% (20/538), and Palliative and Supportive Care (PSC) with 3.64% (9/247) reporting. CONCLUSIONS The overall reporting rate for QoL articles in palliative care journals was 1.95% and there were very few randomized clinical trials and systematic reviews found. The study findings indicate further high-quality research to establish an adequate evidence base for QoL.
Collapse
Affiliation(s)
- Senthil P Kumar
- Department of Physiotherapy, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India
| |
Collapse
|
13
|
Ferriolli E, Skipworth RJE, Hendry P, Scott A, Stensteth J, Dahele M, Wall L, Greig C, Fallon M, Strasser F, Preston T, Fearon KCH. Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy? J Pain Symptom Manage 2012; 43:1025-35. [PMID: 22269181 DOI: 10.1016/j.jpainsymman.2011.06.013] [Citation(s) in RCA: 79] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2011] [Revised: 06/25/2011] [Accepted: 06/28/2011] [Indexed: 11/26/2022]
Abstract
CONTEXT In surgical and clinical oncology, there is a growing need for patient-centered outcomes that are responsive, meaningful, and fit for purpose. OBJECTIVES The aim of this study was to validate physical activity (PA) monitoring as a responsive outcome measure at different stages of disease and treatment, by verifying correlations between PA, performance score, and quality of life (QoL). METHODS Daily life PA of 162 cancer patients, monitored by a device that records time sitting/lying, time standing, time walking, number of steps taken, and walking cadence, was compared with 20 healthy volunteers. In a subgroup of patients, functional status and QoL were assessed using the World Health Organization/Eastern Cooperative Oncology Group and the Karnofsky Performance Status scores and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) questionnaire. RESULTS The PA of patients with resectable gastrointestinal cancer did not differ significantly from controls. In contrast, patients with advanced cancer took 45% fewer steps and spent an extra 2.8 hours/day lying/sitting (P=0.001). Patients undergoing neoadjuvant chemotherapy and surgery (5-6 weeks after operation) experienced a similar reduction in PA. There were significant correlations between PA and the physical and role domains as well as fatigue subscale of the EORTC QLQ-C30 scale. CONCLUSION Objective PA scores correlate significantly with disease stage, functional status, and QoL of patients with cancer. Therefore, activity monitoring can make meaningful objective estimates of patient function in response to cancer and its treatment and may provide surrogate outcomes of QoL.
Collapse
Affiliation(s)
- Eduardo Ferriolli
- Clinical and Surgical Sciences, University of Edinburgh, Royal Infirmary Edinburgh, Edinburgh, Scotland, UK.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Kumar SP. Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review. Indian J Palliat Care 2011; 17:108-15. [PMID: 21976850 PMCID: PMC3183599 DOI: 10.4103/0973-1075.84531] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
The Pain Research Group of the world health organization (WHO) Collaborating Centre for Symptom Evaluation in Cancer Care had developed the Brief Pain Inventory (BPI), a pain assessment tool for use with cancer patients. The BPI measures both the intensity of pain (sensory dimension) and interference of pain in the patient's life (reactive dimension). The objective of this review paper was to provide a detailed update of existing evidence on applicability of BPI in evaluation of patients with cancer pain. The BPI demonstrated good construct and concurrent validity. It was translated and validated into many languages - Brazilian, Chinese, Greek, Hindi, Italian, Japanese, Korean, Malay, Norwegian, Polish, Russian, Spanish, Taiwanese and Thai. The BPI was validated in patient populations such as bone metastases, breast cancer and postoperative cancer patients. The BPI can be used both as a quantitative or a qualitative measure for statistical analysis. The BPI was a powerful tool and, having demonstrated both reliability and validity across cultures and languages, was being adopted in many countries for clinical pain assessment, epidemiological studies, and in studies on the effectiveness of pain treatment. Future studies are warranted on its responsiveness and cross-cultural adaptation into other cancer pain syndromes and into other Indian languages.
Collapse
Affiliation(s)
- Senthil P Kumar
- Department of Physiotherapy, Kasturba Medical College (Manipal University), Mangalore, India
| |
Collapse
|
15
|
Heyn L, Finset A, Eide H, Ruland CM. Effects of an interactive tailored patient assessment on patient-clinician communication in cancer care. Psychooncology 2011; 22:89-96. [PMID: 21919122 DOI: 10.1002/pon.2064] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2011] [Revised: 08/10/2011] [Accepted: 08/10/2011] [Indexed: 11/06/2022]
Abstract
BACKGROUND To test the effect of Choice, an interactive tailored patient assessment (ITPA) tool on the number and types of symptoms addressed during consultations with cancer patients, cancer patients' active participation during consultation with clinicians, and clinicians' responses. METHOD A total of 193 consultations were audio taped and coded with the task-oriented part of Roter Interactive Assessment System. In addition, we recorded the initiator of each coded utterance (clinician or patient) as defined by Verona Coding Definitions of Emotional Sequences and indicated the symptoms addressed in a list of all symptoms within the Choice ITPA. Of the 193 consultations, 99 were standard consultations that served as a control group. In the 94 intervention group consultations, patients utilized the Choice ITPA prior to the consultation, and the assessment summary was available to both patients and clinicians. We compared the two groups in both multilevel and multivariate analyses. RESULTS We found significantly more symptoms addressed in the intervention group as compared with the control group. We also found that the patients asked more questions in the intervention group, indicating that they were more active participants when utilizing Choice. The clinicians also provided more information in the intervention group. CONCLUSION The Choice ITPA was successful in making cancer patients more active participants in the consultation with their clinician.
Collapse
Affiliation(s)
- Lena Heyn
- Center for Shared Decision Making and Nursing Research, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
| | | | | | | |
Collapse
|
16
|
Abstract
PURPOSE OF REVIEW Loss of ability to manage daily activities is source of significant distress for palliative patients. In the context of end-of-life care, rehabilitation contributes to patients' sense of autonomy, self-worth, and social participation. The present article provides an overview of recent advances in rehabilitation in end-of-life management, drawing on papers published during 2009. RECENT FINDINGS Palliative patients have rehabilitation needs including difficulties with activities of daily living, disruption to usual routines and roles, and anxieties about being a burden to others. These needs are not adequately identified, leading to patients receiving less than optimal help in living with disability. Research shows that rehabilitation interventions such as exercise programmes have beneficial effects on fatigue and quality of life. In delivering rehabilitation, staff attitudes are important and should support patients' views of themselves as worthwhile, resourceful individuals. SUMMARY Adequate screening procedures are necessary to identify functional difficulties so that appropriate help might be provided. There is now a growing body of work on the therapeutic benefits of exercise. There is a need for further experimental studies with larger samples to demonstrate effectiveness of interventions, as well as for qualitative studies examining the mechanisms of rehabilitation.
Collapse
|
17
|
Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F. Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 2011; 80:114-44. [PMID: 21216616 DOI: 10.1016/j.critrevonc.2010.10.004] [Citation(s) in RCA: 133] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2010] [Revised: 08/17/2010] [Accepted: 10/05/2010] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND The concept of cancer-related anorexia/cachexia is evolving as its mechanisms are better understood. To support consensus processes towards an updated definition and classification system, we systematically reviewed the literature for items and domains associated with involuntary weight loss in cancer. METHODS Two search strings (cachexia, cancer) explored five databases from 1976 to 2007. Citations, abstracts and papers were included if they were original work, in English/German language, and explored an item to distinguish advanced cancer patients with variable degrees of involuntary weight loss. The items were grouped into the 5 domains proposed by formal expert meetings. RESULTS Of 14,344 citations, 1275 abstracts and 585 papers reviewed, 71 papers were included (6325 patients; 40-50% gastrointestinal, 10-20% lung cancer). No single domain or item could consistently distinguish cancer patients with or without weight loss or having various degrees of weight loss. Anorexia and decreased nutritional intake were unexpectedly weakly related with weight loss. Explanations for this could be the imprecise measurement methods for nutritional intake, symptom interactions, and the importance of systemic inflammation as a catabolic drive. Data on muscle mass and strength is scarce and the impact of cachexia on physical and psychosocial function has not been widely assessed. CONCLUSIONS Current data support a modular concept of cancer cachexia with a variable combination of reduced nutritional intake and catabolic/hyper-metabolic changes. The heterogeneity in the literature revealed by this review underlines the importance of an agreed definition and classification of cancer cachexia.
Collapse
Affiliation(s)
- David Blum
- Oncological Palliative Medicine, Division of Oncology/Hematology, Department of Internal Medicine and Palliative Care Center, Cantonal Hospital, St. Gallen, Switzerland.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Abstract
Palliative care is an interdisciplinary and holistic approach aimed at alleviating suffering from physical, psychosocial, and spiritual issues in progressive, advanced disease. Progressive fatigue and anorexia-cachexia syndrome can contribute to loss of physical function in the palliative cancer patient, to the detriment of overall quality of life. Physical activity is one potential intervention, which may address these needs in the palliative cancer patient. There is preliminary evidence that at least some palliative cancer patients are willing and able to tolerate physical activity interventions, with some patients demonstrating improvement in select supportive care outcomes postintervention. Methodologically rigorous studies and consensus on common definitions are required to advance this area of research.
Collapse
Affiliation(s)
- Sonya S Lowe
- Department of Symptom Control and Palliative Care, Cross Cancer Institute, 11560 University Drive NW, Edmonton, T6G 1Z2, Alberta, Canada.
| |
Collapse
|
19
|
Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T, Costantini A, Fayers P, Helbostad J, Holzner B, Kaasa S, Singer S, Velikova G, Young T. Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimension. Qual Life Res 2010; 20:479-90. [DOI: 10.1007/s11136-010-9770-x] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/04/2010] [Indexed: 11/30/2022]
|
20
|
Current World Literature. Curr Opin Support Palliat Care 2010; 4:207-27. [DOI: 10.1097/spc.0b013e32833e8160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Mueller M, Lohmann S, Thul P, Weimann A, Grill E. Functioning and health in patients with cancer on home-parenteral nutrition: a qualitative study. Health Qual Life Outcomes 2010; 8:41. [PMID: 20398396 PMCID: PMC2862019 DOI: 10.1186/1477-7525-8-41] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2009] [Accepted: 04/16/2010] [Indexed: 12/03/2022] Open
Abstract
Background Malnutrition is a common problem in patients with cancer. One possible strategy to prevent malnutrition and further deterioration is to administer home-parenteral nutrition (HPN). While the effect on survival is still not clear, HPN presumably improves functioning and quality of life. Thus, patients' experiences concerning functioning and quality of life need to be considered when deciding on the provision of HPN. Currently used quality of life measures hardly reflect patients' perspectives and experiences. The objective of our study was to investigate the perspectives of patients with cancer on their experience of functioning and health in relation to HPN in order to get an item pool to develop a comprehensive measure to assess the impact of HPN in this population. Methods We conducted a series of qualitative semi-structured interviews. The interviews were analysed to identify categories of the International Classification of Functioning, Disability and Health (ICF) addressed by patients' statements. Patients were consecutively included in the study until an additional patient did not yield any new information. Results We extracted 94 different ICF-categories from 16 interviews representing patient-relevant aspects of functioning and health (32 categories from the ICF component 'Body Functions', 10 from 'Body Structures', 32 from 'Activities & Participation', 18 from 'Environmental Factors'). About 8% of the concepts derived from the interviews could not be linked to specific ICF categories because they were either too general, disease-specific or pertained to 'Personal Factors'. Patients referred to 22 different aspects of functioning improving due to HPN; mainly activities of daily living, mobility, sleep and emotional functions. Conclusions The ICF proved to be a satisfactory framework to standardize the response of patients with cancer on HPN. For most aspects reported by the patients, a matching concept and ICF category could be found. The development of categories of the component 'Personal Factors' should be promoted to close the existing gap when analyzing interviews using the ICF. The identification and standardization of concepts derived from individual interviews was the first step towards creating new measures based on patients' preferences and experiences which both catch the most relevant aspects of functioning and are sensitive enough to monitor change associated to an intervention such as HPN in a vulnerable population with cancer.
Collapse
Affiliation(s)
- Martin Mueller
- Institute for Health and Rehabilitation Sciences, Ludwig-Maximilians-University, Munich, Germany
| | | | | | | | | |
Collapse
|
22
|
Development of a computer-administered mobility questionnaire. Support Care Cancer 2010; 19:745-55. [DOI: 10.1007/s00520-010-0867-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2009] [Accepted: 03/08/2010] [Indexed: 10/19/2022]
|
23
|
Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T, Costantini A, Fayers P, Helbostad J, Holzner B, Kaasa S, Singer S, Velikova G, Young T. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning. Eur J Cancer 2010; 46:1352-8. [PMID: 20231085 DOI: 10.1016/j.ejca.2010.02.011] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2009] [Accepted: 02/08/2010] [Indexed: 01/24/2023]
Abstract
BACKGROUND Health-related quality of life (HRQOL) questionnaires should ideally be adapted to the individual patient and at the same time scores should be directly comparable across patients. This is achievable using a computerised adaptive test (CAT). Basing the CAT on an existing instrument enables measurement within an established HRQOL framework and allows backward-compatibility with studies using the original instrument. Because of these advantages the EORTC Quality of Life Group (QLG) has initiated a project to develop a CAT version of the widely used EORTC QLQ-C30. METHODS We present the EORTC QLG's strategy for developing a CAT. For each dimension of the EORTC QLQ-C30 our approach includes literature search and conceptualisation, formulation of new items, expert and patient evaluations, field-testing, and psychometric analyses of the items. The strategy is illustrated with the initial results of the development of CAT for physical functioning (PF). RESULTS We identified 975 PF items in the literature. Of these, 407 items were deemed relevant, i.e. measured one of the PF aspects measured by the QLQ-C30. Based on these items we developed 86 new items. Review by the EORTC CAT-project group reduced this to 66 items. Based on expert and patient evaluations several items were revised and the list was further reduced to 51 items. CONCLUSIONS Based on the findings for PF, we believe that our approach will generate item pools that are relevant and appropriate for cancer patients. These will form the basis for a backward-compatible CAT assessing the HRQOL dimensions of the EORTC QLQ-C30.
Collapse
Affiliation(s)
- Morten Aa Petersen
- The Research Unit, Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Fyllingen EH, Oldervoll LM, Loge JH, Hjermstad MJ, Haugen DF, Sigurdardottir KR, Paulsen O, Kaasa S. Computer-based assessment of symptoms and mobility in palliative care: feasibility and challenges. J Pain Symptom Manage 2009; 38:827-36. [PMID: 19833476 DOI: 10.1016/j.jpainsymman.2009.05.015] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2009] [Revised: 04/30/2009] [Accepted: 05/14/2009] [Indexed: 11/16/2022]
Abstract
The aims of the study were to explore the ability of cancer patients who are primarily receiving palliative care to use a touchscreen computer for assessment of symptoms and mobility and to investigate which factors predicted the need for assistance during the assessment. Before the main data collection, a pilot study was conducted to explore the preferences of these patients toward using such a computerized assessment tool. Patients were recruited from nine different inpatient and outpatient palliative care and general cancer clinics in Norway. The patients responded to 60 items on symptoms and mobility directly on the computer. In the pilot study (n=20), 11 patients (55.0%) preferred computerized assessment over paper and pencil, whereas five (25.0%) had no preference. In the main data collection, 370 patients (52.7% men with mean age 62 years and mean Karnofsky Performance Status score of 70) completed the assessment. Eighty-six patients (23.2%) required assistance. Patients requiring assistance were significantly older, had worse performance status, and poorer cognitive function than those not requiring assistance. Predictors for requiring assistance were age (P<0.001) and performance status (P<0.001). Because higher age and worse performance status resulted in more need of assistance, assessment tools should be short and user-friendly to ensure good compliance in frail patients.
Collapse
Affiliation(s)
- Even Hovig Fyllingen
- Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
| | | | | | | | | | | | | | | | | |
Collapse
|